Vetnostrum Animal Health Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Revenue	1,369	1,294	1,208	1,185
Revenue Growth (YoY)	11.76%	7.17%	1.87%	-
Cost of Revenue	932.9	853.42	850.75	832.13
Gross Profit	436.07	440.69	356.76	353.23
Selling, General & Admin	253.17	241.18	219.87	209.09
Research & Development	33.61	28.78	25.46	19.51
Operating Expenses	286.78	269.96	245.22	228.61
Operating Income	149.28	170.73	111.54	124.62
Interest Expense	-0.57	-1.1	-1.97	-2.92
Interest & Investment Income	2.01	0.65	0.54	0.14
Other Non Operating Income (Expenses)	-3.19	-0.57	2.92	9.18
Pretax Income	147.53	169.72	113.03	131.01
Income Tax Expense	27.96	33.1	21.43	24.5
Net Income	119.57	136.62	91.6	106.52
Net Income to Common	119.57	136.62	91.6	106.52
Net Income Growth	10.07%	49.15%	-14.01%	-
Shares Outstanding (Basic)	69	66	66	63
Shares Outstanding (Diluted)	69	66	66	63
Shares Change (YoY)	4.00%	-0.09%	4.69%	-
EPS (Basic)	1.72	2.06	1.38	1.69
EPS (Diluted)	1.72	2.06	1.38	1.68
EPS Growth	5.85%	49.28%	-17.86%	-
Free Cash Flow	129.27	150.19	220	105.51
Free Cash Flow Per Share	1.86	2.27	3.31	1.66
Gross Margin	31.85%	34.05%	29.54%	29.80%
Operating Margin	10.90%	13.19%	9.24%	10.51%
Profit Margin	8.73%	10.56%	7.59%	8.99%
Free Cash Flow Margin	9.44%	11.61%	18.22%	8.90%
EBITDA	223.98	246.88	188.28	202.84
EBITDA Margin	16.36%	19.08%	15.59%	17.11%
D&A For EBITDA	74.7	76.15	76.74	78.22
EBIT	149.28	170.73	111.54	124.62
EBIT Margin	10.90%	13.19%	9.24%	10.51%
Effective Tax Rate	18.95%	19.50%	18.96%	18.70%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.